| Aug 8 |
Cybin reports Q1 results
|
| Aug 8 |
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
|
| Aug 7 |
Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
|
| Jul 8 |
A Swell Of Insider Purchases Follow Cybin Inc.'s Positive Year-End Update
|
| Jun 27 |
What Makes Cybin Inc. (CYBN) a New Buy Stock
|
| Jun 26 |
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
|
| Jun 19 |
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
| Jun 11 |
Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround
|
| Jun 11 |
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
|
| May 29 |
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
|
